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Research background. The occurrence and environmental toxicity of pharmaceuticals 
have recently attracted increasing attention. Diclofenac is a highly consumed non-steroi-
dal anti-inflammatory drug, which is often detected in wastewaters, but investigations of 
its influence on bacteria are scarce. 
Experimental approach. We investigated the influence of this pharmaceutical on bacte-
rial community in activated sludge exposed to increasing concentrations of diclofenac in 
fed-batch reactors over 41 days. Nitrification activity of the activated sludge was measured 
and changes in bacterial community structure were followed using culture-independent 
molecular method (terminal restriction fragment length polymorphism, T-RFLP) and by 
the cultivation approach. 
Results and conclusions. Nitrification activity was not detectably influenced by the ad-
dition of diclofenac, while the main change of the bacterial community structure was de-
tected only at the end of incubation (after 41 days) when diclofenac was added to artificial 
wastewater as the only carbon source. Changes in community composition due to enrich-
ment were observed using cultivation approach. However, taxonomic affiliation of isolates 
did not match taxons identified by T-RFLP community profiling. Isolates obtained from 
activated sludge used as inoculum belonged to five genera: Comamonas, Arthrobacter, 
Acinetobacter, Citrobacter and Aeromonas, known for their potential to degrade aromatic 
compounds. However, only Pseudomonas species were isolated after the last enrichment 
step on minimal agar plates with diclofenac added as the sole carbon source. 
Novelty and scientific contribution. Our results suggest that the selected recalcitrant 
and commonly detected pharmaceutical does not strongly influence the sensitive and 
important nitrification process of wastewater treatment. Moreover, the isolated strains 
obtained after enrichment procedure that were able to grow on minimal agar plates with 
diclofenac added as the only carbon source could serve as potential model bacteria to 
study bacterial diclofenac degradation. 
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INTRODUCTION
Pharmaceuticals, generally regarded as being extremely advantageous for increasing 
human life expectancy, on the other hand represent a serious burden for the environment. 
Worldwide consumption rates of hundreds of tonnes of pharmaceuticals have a potential 
to cause undesirable ecological and human health effects (1–3). The pharmaceutical in-
dustry has increased enormously in recent years and currently represents one of the most 
profitable branches of industry. Consequently, substantial amounts of pharmaceuticals 
can reach and impact the environment, either through direct discharge of pharmaceuticals 
or due to inefficient elimination in wastewater treatment plants (WWTPs). Several studies 
have demonstrated that some pharmaceuticals are efficiently eliminated by WWTPs (ibu-
profen, naproxen, ketoprofen), while others are resistant to biodegradation (diclofenac, 
clofibric acid) (4–7). Although many pharmaceuticals and their metabolites have been 
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detected in aquatic environments and even in drinking water 
samples at concentrations ranging from ng/L up to hundreds 
of μg/L (4,8–10), there still remains a limited understanding of 
the extent and magnitude of their ecological effects.
Diclofenac is a non-steroidal anti-inflammatory drug 
(NSAID) prescribed in daily doses of 75–150 mg to reduce in-
flammation. It acts as an analgesic to reduce pain in patients 
with arthritis or acute injury and can even be used to reduce 
menstrual pain (11). Over the counter use of diclofenac is ap-
proved in some countries for minor pains and fever associat-
ed with common infections, and it has been estimated that 
940 tonnes are consumed annually worldwide (11). Chemical-
ly, diclofenac is 2-[(2,6-dichlorophenyl)amino]-benzeneacetic 
acid. One benzene ring is chlorinated, which contributes to 
the recalcitrant nature of this pharmaceutical for biological 
degradation. The highly variable and relatively low biodeg-
radation of diclofenac in WWTPs has been reported, main-
ly in the range of 21–40 % (11). In the aquatic environment, 
diclofenac is one of the most frequently detected pharma-
ceuticals (12). It has been detected in drinking water (12) and 
has caused the death of millions of vultures in Southeast Asia 
through its use in veterinary medicine (13,14). In the liver, kid-
neys and gills of rainbow trout, cytopathology occurred al-
ready at concentrations of 1 μg/L (15). Studies of diclofenac 
influence on microbial communities are scarce. Microorgan-
isms in lotic biofilms were inhibited at diclofenac concentra-
tions of 100 μg/L (16). At very high concentrations (50–100 
mg/L), it was shown to inhibit bacterial growth in most of the 
tested Gram-positive and Gram-negative strains by inhibiting 
DNA synthesis (17).
In our previous studies (18,19), we have shown that a mix-
ture of selected commonly used pharmaceuticals including 
diclofenac caused shifts in the community structure of acti-
vated sludge in pilot bioreactors. The aim of this study is to 
evaluate the effect of diclofenac, the most recalcitrant drug 
in the pharmaceutical mixture (5), on the nitrification activity 
and the community structure of activated sludge in fed-batch 
reactors exposed to increasing concentration of diclofenac. 
Additionally, we used the enrichment culture approach to iso-
late bacteria that are capable of growing on minimal agar 
plates with diclofenac added as the only carbon source. 
MATERIALS AND METHODS
Experimental setup and sampling
Batch cultures of activated sludge were prepared in 500-
-mL Erlenmeyer flasks containing 200 mL of artificial waste-
water, which was prepared by dissolving a mineral nutrient 
composition in tap water, simulating the composition of real 
municipal wastewater (5). The following chemicals were used: 
yeast extract (130 mg/L), casein peptone (130 mg/L), meat ex-
tract (130 mg/L; all Biolife Italiana, Milano, Italy), CH3COONH4 
(317 mg/L), NH4Cl (40 mg/L; both Kemika, Zagreb, Croa-
tia), K2HPO4 (24 mg/L), KH2PO4 (8 mg/L), CaCO3 (100 mg/L), 
MgCO3 (100 mg/L), NaCl (40 mg/L; all Sigma-Aldrich, Merck, 
Gillingham, UK) and FeSO4·7H2O (5 mg/L; Merck, Darmstadt, 
Germany). Each flask (fed-batch reactor) was inoculated with 
20 mL of activated sludge obtained from the R200 reactor 
described by Kraigher et al. (18), which was operated for 18 
months with artificial wastewater containing 200 μg/L of 
each of the following pharmaceuticals: diclofenac, ibuprofen, 
naproxen, ketoprofen and clofibric acid. This sludge was se-
lected because it contained a biomass already adapted to the 
selected concentration of pharmaceuticals and it was expect-
ed that potential changes in community structure and en-
richment of bacteria capable of degrading diclofenac would 
be detected sooner. Fed-batch reactors were incubated at 
220 rpm and 28 °C in the darkness. Activated sludge was ex-
posed to either 200 μg/L diclofenac (Sigma-Aldrich, Merck) 
throughout the entire experiment, or to 5 mg/L diclofenac 
(with increasing concentrations from 1 to 5 mg/L in the first 
10 days of incubation). One fed-batch reactor was incubated 
without the addition of pharmaceuticals. The fed-batch reac-
tors were operated in the following way throughout the ex-
periment: the hydraulic retention time of two days was main-
tained by settling down the sludge every two days (three 
days over the weekends), decanting the medium, and add-
ing fresh artificial wastewater with (or without) diclofenac. 
Each time the samples of influents (artificial wastewater) and 
effluents (decanted medium) were taken and kept frozen un-
til N-NH4+ and N-(NO2–+NO3–) concentrations were analysed 
by continuous flow analyser (FlowSys Alliance Instruments, 
Salzburg, Austria). After 20 days of incubation, the artificial 
wastewater without organic carbon (i.e. without casein pep-
tone, CH3COONH4, meat and yeast extract) was used to feed 
the fed-batch reactors which were incubated for additional 
three weeks. Activated sludge for bacterial community analy-
ses was sampled (1 mL) at indicated time intervals and stored 
at –80 °C until DNA extraction. 
Bacterial community analyses
Terminal restriction fragment length polymorphism 
(T-RFLP) analysis was used to compare bacterial community 
structures. DNA was extracted from 1-mL subsamples (two 
independent DNA isolations were obtained for each sam-
ple) using the UltraClean soil DNA isolation kit (MoBio Solano 
Beach, CA, USA) according to the manufacturer’s instructions. 
Isolated total community DNA (concentration of 50–100 ng/
μL) was checked on a 1 % agarose gel and compared to the 
Gene Ruler DNA Ladder Mix (Thermo Fisher Scientific Bal-
tics, UAB, Vilnius, Lithuania) to estimate the size and concen-
tration. Purified DNA was then used as a template for pol-
ymerase chain reaction (PCR) with 16S rRNA gene primers 
27f labelled with 6-FAM (6-carboxyfluorescein) at the 5’ end 
and 927r (20) for the total community analyses, following the 
protocols described by Kraigher et al. (18). Restriction with re-
striction enzyme MspI (Thermo Fisher Scientific Baltics, UAB), 
ethanol precipitation and T-RFLP profiling were performed. 
Profiles were generated using ABI PRISM 310 DNA sequenc-
er and GeneScan analysis software (21). Terminal restriction 
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fragments (T-RFs) with peak heights of less than 50 fluores-
cence units and T-RFs that were less than 50 bp long were 
excluded from the analyses. T-RFLP profiles of duplicate DNA 
isolations per sample were analysed using the BioNumerics 
program v. 6.6 (22). Normalized intensity values and the po-
sitions of the detected bands were used for cluster analysis, 
while peaks representing less than 1 % of the total fluores-
cence of all peaks in a sample were excluded from the anal-
ysis. Pearson’s correlation coefficient, which considers both 
fragment length and peak height, was used to calculate simi-
larity coefficients. A dendrogram was then constructed using 
the unweighted pair-group method with arithmetic means 
(UPGMA) algorithm. 
Isolation of bacteria capable of growing 
on minimal plates with diclofenac
Bacteria were isolated from the activated sludge that was 
used as inoculum for the incubation experiment and from 
the fed-batch cultures at the end of the experiment (after 
41 days of incubation with diclofenac, with the last 20 days 
without the addition of any other external carbon source ex-
cept for diclofenac). Mineral medium (MM) agar plates sup-
plied with 20 mg/L of diclofenac as the only carbon and 
energy source were used for isolation. MM agar plates con-
sisted of (in g/L): 3.5 Na2HPO4·2H2O (Sigma-Aldrich, Merck), 
1 KH2PO4 (Sigma-Aldrich, Merck), 0.5 (NH4)2SO4·2H2O (Merck), 
0.1 MgCl2·6H2O (Honeywell-Fluka, Basel, Switzerland), 0.05 
Ca(NO3)2·4H2O (Honeywell-Fluka), 15 highly purified agar (Bi-
olife Italiana) at pH=7.25 and finally 1 mL trace element solu-
tion SL-4 was added. The trace element solution SL-4 consist-
ed of (in g/L): 0.5 EDTA (Sigma-Aldrich, Merck), 0.2 FeSO4·7H2O 
(Merck), 0.01 ZnSO4·7H2O (Merck), 0.003 MnCl2·4H2O (Merck), 
0.03 H3BO3 (Merck), 0.02 g CoCl2·6H2O (Honeywell-Fluka), 
0.001 g CuCl2·2H2O (Sigma-Aldrich, Merck), 0.002 NiCl2·6H2O 
(Sigma-Aldrich, Merck) and 0.003 Na2MoO4·2H2O (Kemika). 
The activated sludge was centrifuged, washed with MM me-
dium and then different dilutions were plated on MM plates 
with diclofenac and incubated in darkness at 28 °C. Distinct 
colonies were reinoculated on R2A plates (R-2A agar; Flu-
ka Analytical, Sigma-Aldrich Chemie GmbH, Merck) several 
times until pure cultures were obtained, and then verified for 
growth on MM plates with diclofenac as a sole carbon source. 
Finally, purified colonies were grown overnight in yeast ex-
tract broth consisting of (in g/L): 3 yeast extract and 6 pepto-
complex (Biolife Italiana), then frozen in glycerol (15 %) and 
stored at –80 °C. 
Identification of the isolated bacteria
The isolated bacteria were grown in yeast extract broth 
(Biolife Italiana), overnight at 28 °C and 220 rpm in darkness. 
The overnight cultures were then boiled for 10 min and 3 μL 
of boiled cells were used as a template to amplify the 16S 
rRNA genes using primers 27f and 1406R (23) and PCR con-
ditions as described above for T-RFLP. PCR reactions were 
purified with QuickClean 5M PCR purification kit (GenScript 
USA Inc., Piscataway, NJ, USA) and sequenced by Macrogen 
Inc. (Seoul, Korea). Sequences of 700–800 bp were obtained. 
Some isolates were selected for sequencing with both for-
ward and reverse primers (which gave approx. 300 bp of over-
lapping sequence) to get more reliable information about the 
identity of the isolates. The partial 16S rRNA gene sequences 
were identified by Basic Local Alignment Search Tool (BLAST; 
(24)) searches at NCBI and deposited in the GenBank database 
under accession numbers JF928537 to JF928555. GenBank se-
quences, which were identified by BLAST searches to be most 
similar to the isolate sequences, were downloaded and in-
cluded in the phylogenetic tree reconstruction using neigh-
bour-joining method with 500 bootstrap replicates and the 
Maximum Composite Likelihood evolutionary model within 
the MEGA v. 4 (25). 
RESULTS AND DISCUSSION
Nitrification activity during the experiment 
Studies of xenobiotics in activated sludge generally fo-
cus on their degradation efficiency. However, it is also very 
important to investigate the influence of xenobiotics on mi-
crobial activities responsible for the key functions of WWTPs, 
such as nitrogen removal. In the previous study (19), a high-
er concentration of nitrate was detected in the reactors con-
taining 50 μg/L of the pharmaceutical mix than in the reac-
tors with lower concentration of pharmaceutical mix (5 or 0 
μg/L), while no significant influence of pharmaceuticals on 
ammonium removal was observed. In this study, nitrification 
activity of the activated sludge in the fed-batch reactors ex-
posed to diclofenac was monitored every two to three days 
after settling down the sludge by measuring ammonium, ni-
trite and nitrate concentrations in the medium (Fig. 1). Ni-
trification performance as reflected by ammonium removal 
was high in all batch reactors (nearly 100 %), irrespective of 
the diclofenac concentration (Fig. 1a). A short adaptation pe-
riod was observed during the first 4–6 days when the seed-
ing sludge was transferred from the pilot reactor to the fed- 
-batch reactors without diclofenac or its lower concentration 
(200 μg/L). This lag period was not observed in the fed-batch 
reactors with a high concentration of diclofenac (1 mg/L at 
the beginning). However, irrespective of diclofenac concen-
tration, almost no ammonium (mostly less than 0.5 mg/L) re-
mained in the fed-batch reactors after six days of incubation. 
A longer adaptation period for nitrite oxidation was observed 
as its accumulation was detected for 13–15 days (Fig. 1b). Af-
ter this period, nitrite almost totally disappeared, while ni-
trate concentrations increased. After the first 20 days, when 
all carbon sources except diclofenac were excluded and the 
influent ammonium concentration was lower (it dropped 
from approx. 65 to approx. 9.5 mg/L when all carbon sourc-
es were eliminated), the concentration of nitrate fell rapidly 
and was relatively constant in all fed-batch reactors until the 
end of the experiment (Fig. 1c). In the previous study (19), the 
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concentration of nitrate in the effluent of the reactors was 
very low (except in the reactors with 50 μg/L of pharmaceu-
ticals). This was attributed to the denitrification in the reac-
tors under the microaerophilic conditions that were proba-
bly present in the activated sludge flocs. In contrast, in this 
experiment the reactors were thoroughly shaken and flocs 
could not develop. However, despite different conditions in 
the pilot reactors and fed-batch reactors used in this experi-
ment, ammonium removal was high in both systems and inhi-
bition of nitrification process by diclofenac was not detected. 
Bacterial community shifts during the experiment
The bacterial community structure of activated sludge in 
the fed-batch reactors was evaluated by T-RFLP at the begin-
ning of the experiment, after 20 days of incubation with di-
clofenac (0.2 or 5 mg/L) and at the end of the experiment (41 
days), when the sludge was incubated for the last 21 days with 
diclofenac as the only carbon source. Comparison of T-RFLP 
profiles of bacterial communities is shown as a dendrogram 
in Fig. 2. Community profiles representing inoculum and the 
first four days of experiment (samples designated t0, 2d, 4d), 
clustered separately from the samples after 20 days (samples 
designated 20d) and after 41 days (41d) of incubation, indi-
cating shifts in bacterial communities over time. This could 
partly be attributed to the adaptation to the altered condi-
tions when transferring the sludge from the pilot reactors 
to the fed-batch reactors (communities diverged to approx. 
65 % similarity). The highest divergence (only approx. 40 % 
similarity) was observed when all carbon sources were ex-
cluded from the artificial wastewater and diclofenac served 
as the only carbon source (Fig. 2). Also, the community pro-
file of the sludge incubated without diclofenac diverged 
most from the other two communities at the end of the ex-
periment. The similarity among the replicate samples was at 
least 80 %, while similarity between fed-batch reactors with 
or without diclofenac at the end of the experiment was ap-








































































Fig. 2. Comparison of the activated sludge bacterial community profiles treated with different 
concentrations of diclofenac at three different times of incubation. The dendrogram of the terminal 
restriction fragment length polymorphism (T-RFLP) profiles was generated based on Pearson’s 
correlation using the unweighted pair-group method with arithmetic means (UPGMA) method. 
0=reactor without diclofenac, Dc200=reactor with γ(diclofenac)=200 μg/L, Dc=reactor with increasing 
diclofenac concentration up to 5 mg/L, t0=activated sludge used for seeding the flasks, A and B=DNA 


























Fig. 1. The concentrations of: a) ammonium, b) nitrite and c) nitrate in 
the small fed-batch reactors during the experiment. Vertical dashed 
lines indicate the time point where all carbon sources except di-
clofenac were excluded from the influent artificial wastewater. Dc= 
flask with increasing diclofenac concentration up to 5 mg/L, Dc200= 
flask with γ(diclofenac)=200 μg/L, 0=flask without diclofenac, influ-
ent=artificial wastewater used to feed the reactors
Fig. 2. Comparison of the activated sludge bacterial community pro-
files treated with different concentrations of diclofenac at three dif-
ferent times f incubation. The dendrogram of the termi al restric-
tion fragment length polymorphism (T-RFLP) profiles was generated 
based on Pearson’s correlation using the unweighted pair-group 
method with arithmetic means (UPGMA) method. 0=reactor without 
diclofenac, Dc200=reactor with γ(diclofenac)=200 μg/L, Dc=reactor 
with increasing diclofenac concentration up to 5 mg/L, t0=activated 
sludge used for s eding the flasks, A and B=DNA isolations from d -
plicate samples, 2d, 4d, 20d, 41d=samples taken after 2, 4, 20 and 41 
days of the incubation
Fig. 3 shows the T-RFLP profiles of some representative 
samples. Major differences could be observed in the profiles 
at the end of incubation, where at least two new peaks are 
evident. One of the two T-RF peaks was present in all samples 
at the end of the experiment (on the right end of the profiles, 
the length was not estimated since it was already above the 
range of our standard, which was 500 bp) and could be at-
tributed to the absence of carbon sources during the last 21 
days of incubation. We affiliated the most distinctive peak, 
which clearly appeared only in the fed-batch reactors with 
diclofenac and not in the control (Fig. 3), with T-RF of 292 bp. 
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This peak was identified by in silico T-RFLP analyses of the 
clone library constructed previously (18), considering the T-RF 
drifts of in silico predicted and the experimental T-RF lengths 
of approx. 4 bp (19). Based on our previous analyses (19) the 
292 bp T-RF could be affiliated with Acidobacteria phylum. 
Representatives of this phylum are very difficult to isolate 
(only a few representatives have been isolated so far) and 
are therefore not well characterized metabolically, although 
molecular analyses indicate their widespread presence across 
variety of environments (26,27).
Our results indicated that there was no significant in-
fluence of dicofenac on the bacterial community structure 
in activated sludge during the first 20 days of the experi-
ment, when additional carbon was still present, even if its 
concentration was 5 mg/L. This is not surprising as the com-
munity has been previously adapted to a variety of pharma-
ceuticals. Moreover, consistently with Zhang et al. (11), who 
reported relatively low degradation efficiency for diclofenac 
in WWTPs, bacteria will preferentially degrade more easily 
degradable carbon source. However, a detectable change in 
bacterial community structure occurred when diclofenac was 
provided as the only carbon source and other carbon sources 
were removed. This change indicates that one or more micro-
bial types became enriched in the setting and that adapted 
sludge has a potential for growth on diclofenac and conse-
quently its removal. However, we cannot exclude the possibil-
ity that this shift might be the result of enrichment of certain 
diclofenac-tolerant community members that grow on dead 
biomass. Therefore, further studies are needed to character-
ize the species responsible for the changed pattern. 
Isolation of bacteria capable of growth on minimal 
agar plates with diclofenac as a sole carbon source
As we observed a change in microbial community struc-
ture due to diclofenac, we aimed to isolate the bacteria ca-
pable of growing on minimal medium containing diclofenac 
as the only carbon source. Bacteria were isolated from the 
original bioreactor sludge used for inoculating the fed-batch 
reactors and from the sludge exposed to higher concentra-
tions of diclofenac after the 41-day experiment. From the first 
sample, representatives of five genera were isolated, while 
after incubation in the absence of other sources of carbon 
during the last 21 days of experiment, only two different 
Pseudomonas sp. were isolated. In Fig. 4, a phylogenetic tree 
indicates the affiliation of the isolates obtained in this study 
with the related strains found by BLAST searches of the 16S 
rRNA genes. Eleven isolates from the seeding sludge desig-
nated Dc1-Dc11 belonged to Gammaproteobacteria, Betapro-
teobacteria and Actinobacteria. From the activated sludge in 
fed-batch reactors, after enrichment experiment we isolated 
eight strains (Dc21–Dc28) which were taxonomically less di-
verse and belonged to Pseudomonas sp. (Gammaproteobacte-
ria). Changes in the community structure before and after the 
enrichment with diclofenac as the only carbon source were 
detected by culture-independent molecular methods as well 
as with the selective isolation of bacteria capable of growing 
on diclofenac. Affiliations and identities of partial 16S rRNA 
genes of the isolates with the related strains are shown in Ta-
ble 1. Five species isolated from the seeding sludge showed 
99–100 % sequence identity to related strains in the GenBank, 
which harbour representatives previously indicated for their 
potential to degrade aromatic compounds. Majority (7) of the 
obtained isolates were relatives of Comamonas testosteroni, 
which is able to mineralize complex and xenobiotic aromat-
ic compounds as the sole carbon and energy source (28,29). 
Boon et al. (30) demonstrated that wastewater reactors aug-
mented by C. testosteroni I2 gfp showed accelerated degrada-
tion of toxic chlorinated aromatic compound 3-chloroaniline. 
This strain also protected the nitrifying bacterial community, 
allowing for its faster recovery from the toxic shocks. Acineto-
bacter sp. and Arthrobacter sp. HY2 degraded p-nitrophenol 
(31,32), while Citrobacter strains isolated from various effluent 
treatment plants degraded a range of aromatic compounds 
and biotransformed mono- and dichlorophenols (33). Species 
from the genus Aeromonas are commonly reported in clini-
cal studies, but they also degrade aromatic compounds (34). 
Although the same method of isolation was used for all 
isolates in this work, the isolates from the seeding sludge 
were more diverse than those exposed to diclofenac with-
out other carbon sources. The seeding sludge from the reac-
tor was exposed for 18 months to diclofenac (in a mixture of 
five different pharmaceuticals at concentration of 200 µg/L) 





                               
Fig. 3. Terminal restriction fragment length polymorphism (T-RFLP) profiles of the bacterial 
communities in the flasks at different times of incubation. The most distinctive change in the T-RF of 
292 bp (indicated by an arrow) occurred in the flasks treated with diclofenac without any other carbon 
source. The other T-RF indicated occurred in all flasks at the end of the experiment. t0=activated 
sludge used for seeding the flasks, 0=reactor witho t diclofenac, Dc200=reactor with 
γ(diclofenac)=200 μg/L, Dc=reactor with increasing diclofenac concentration up to 5 mg/L, 2d, 20d, 
41d=samples taken after 2, 20 and 41 days of incubation experiment 
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wastewater, which enabled the growth of co-metaboliz-
ing bacteria, while in the fed-batch reactors, enrichment of 
bacteria able to utilize diclofenac as the sole carbon source 
was favoured. Seven out of eight Pseudomonas isolates were 
affiliated with Pseudomonas putida (Fig. 4), which is a meta-
bolically versatile bacterium closely related to P. aeruginosa 
and important for bioremediation of sites contaminated with 
multiple aromatic hydrocarbons. The partial 16S rRNA gene 
Table 1. Identification and similarity of the isolates with the known species as found by Basic Local Alignment Search Tool (BLAST) searches in 
the GenBank (22)
Strains with sequences similar to the isolates  













Comamonas testosteroni I2gfp (EF421407) 
Comamonas sp. PD3 (EF373535)
1299/1299 (100) 
1297/1299 (99.9)
3-chloroaniline-degrading Comamonas testosteroni strain, 
I2gfp, isolated from wastewater
phenol-degrading bacteria
Aeromonas media 480a (FJ168773) 1309/1311 (99.9) analysis of 16S rRNA gene mutations in a subset of Aeromonas strains
Arthrobacter sp. R4 (FN392695)
Arthrobacter sp. TD3 (EF468655)




microcystin-degrading bacteria isolated from water
2,4,6-trinitrotoluene-degrading bacteria
bacteria isolated from sewage sludge compost
Citrobacter gillenii (AF025367) 1304/1305 (99.9) Citrobacter phylogeny by 16S rRNA gene sequence comparison
Acinetobacter sp. E-9 (FJ392124) 
Acinetobacter sp. bk_2 (HQ538658)
1261/1263 (99.8) 
1299/1301 (99.9)
phenol-degrading bacteria isolated from leaf microbial 
communities













P. putida PNP-1 (EU874452)
P. putida PL2 (FJ204928) 
P. putida F1 (NC009512)  
P. putida KT2440 (NC002947)
P. aeruginosa LESB58 (NC011770)
1299/1299 (100)
1298/1299 (99.9)  
1299/1299 (100)  
1298/1299 (99.9)
1256/1308 (96.0)
p-nitrophenol-degrading bacteria isolated from soil
strain capable of biodegrading polycyclic aromatic 
hydrocarbons isolated from polluted soil
completely sequenced Pseudomonas putida F1, isolated from 
a polluted creek in Urbana, IL, USA
complete genome sequence of Pseudomonas putida KT2440
the Liverpool epidemic strain of Pseudomonas aeruginosa
 Dc23 JF928551 





P. fluorescens PC17 AY538263 
 Dc28 JF928548 
 Pseudomonas sp. R20808 AJ786776 
P. aeruginosa LESB58 NC 011770 
Pseudomonas sp. 
 Dc7 JF928542 
C. gillenii AF025367 
A. hydrophila 12H341 AB473001 
Dc3 JF928538 
 Aeromonas media 480a FJ168773 
Acinetobacter sp. bk2 HQ538658 
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A. protophormiae SSCT48 AB210984 
Dc5 JF928540 
















P. putida KT2440 NC 002947
 Dc27 JF928547 
 P. putida PNP1 EU874452      
 Dc26 JF928554 
 P. putida PL2 FJ204928 
Dc21 JF928550 
Fig. 4. Phylogenetic tree based on partial 16S rRNA gene sequences showing the affiliations of the isolates obtained in this study (printed bold) 
to similar known species found by Basic Local Alignment Search Tool (BLAST) searches in the GenBank database (22). The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (500 replicates) is shown at the nodes
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sequence of our isolate was 100 % similar to that of P. putida 
F1, which is one of the most well-studied aromatic hydrocar-
bon-degrading bacterial strains (35). 
Importance of the isolated bacteria
Many bacteria which are able to degrade different pollut-
ants are being isolated from various polluted environments. 
Our results suggest that the same species or genera previ-
ously characterized to be metabolically versatile and able 
to degrade diverse aromatic compounds, emerging in the 
environment, might also be able to degrade diclofenac. In 
comparison with ibuprofen, the diclofenac phenol ring is 
halogenated, which contributes to the recalcitrance of this 
drug. However, when we performed similar enrichment ex-
periments with ibuprofen instead of diclofenac, almost iden-
tical bacteria were isolated (as reflected from partial 16S 
rRNA gene sequence; data not shown). In addition, shifts in 
microbial community structure were very similar to the di-
clofenac-enriched community, as the same distinctive T-RF 
occurred in the presence of both pharmaceuticals when oth-
er carbon sources were absent (data not shown). 
We performed T-RFLP analyses of the isolated strains to 
identify specific T-RFs in the total community profiles. These 
only represented very minor T-RFs (with low relative peak 
heights), suggesting that the isolated bacteria are not the 
most abundant in polluted environments. None of the iso-
lates corresponded to the distinctive T-RF of 292 bp, enriched 
at the end of incubation with diclofenac as the only carbon 
source. It seems that bacteria in the activated sludge repre-
senting this T-RF cannot be isolated by the method applied 
here and alternative approaches will need to be devised in 
the future. Nevertheless, we isolated seven strains capable 
of growing on minimal medium with diclofenac as a sole car-
bon source and these represent potential models that can be 
applied to better understand the metabolism of diclofenac 
and study their potential for its removal from wastewater in 
monoculture and in more complex communities, such as ac-
tivated sludge.
Since pharmaceuticals are usually present in wastewaters 
at concentrations of μg/L or less, it is possible that they do not 
serve as the sole carbon sources for the wastewater microor-
ganisms and degradation in the presence of high concentra-
tions of many different carbon sources is probably more rel-
evant for the degradation of diclofenac in WWTPs. Gröning 
et al. (36) have proposed that the apparent lack of degrada-
tive potential of diclofenac as well as the failure to detect an 
enrichment of diclofenac-depleting microbial activity both 
indicate a co-metabolic nature of diclofenac transformation. 
Similarly, Pieper (37) suggested that polychlorinated biphe-
nyl (PCB)-degrading organisms do not usually use PCBs as an 
energy source, but rather catabolize these substrates co-met-
abolically. In fact, there are a few reports in the recent years 
about the degradation of diclofenac: some indicate white-
rot fungi as biodegraders (38), while the first bacterium ca-
pable of using diclofenac as its sole carbon source has been 
reported only recently (39). They showed that the isolated 
strain Brevibacterium sp. D4 could biodegrade 35 % of di-
clofenac as a sole carbon source, while periodic feeding with 
acetate as a supplementary carbon source enhanced biodeg-
radation to the levels up to 90 %. Similarly, it was demonstrat-
ed that the isolated strain Enterobacter hormaechei D15 could 
biodegrade diclofenac at an elimination rate of 52.8 %, while 
in the presence of glucose as a supplementary carbon source, 
degradation rate increased to approx. 82 % (40). Our prelim-
inary assays of diclofenac degradation by the isolated bac-
teria have similarly indicated better elimination rates when 
tests were performed in the presence of other carbon sourc-
es in addition to diclofenac. This might be a consequence of 
the co-metabolic nature of diclofenac degradation or merely 
the lower growth rate of the isolates when only diclofenac is 
available as a carbon source. Evidently, co-metabolism of di-
clofenac is more efficient than its degradation as a sole car-
bon source and search for bacteria in a consortium able to 
degrade it co-metabolically should be adapted accordingly. 
CONCLUSIONS
Our results indicate that nitrification process in small fed-
-batch reactors was efficient and was not detectably affect-
ed by relatively high concentrations of diclofenac (up to 5 
mg/L), suggesting that the selected recalcitrant and com-
monly detected pharmaceutical does not influence the sen-
sitive and important process of wastewater treatment. More-
over, bacterial communities adapted to 0.2 mg/L diclofenac 
did not strongly change at higher diclofenac concentrations 
(5 mg/L), at least under the conditions applied in our exper-
iment, which could explain the low diclofenac degradation 
efficiency often observed in wastewater treatment plants. In-
fluence of diclofenac at concentrations of 0.2 and 5 mg/L on 
the structure of activated sludge microbial communities was 
only evident when other carbon sources were not added. The 
isolated strains obtained in this study are very important as 
potential model bacteria to study bacterial diclofenac deg-
radation. However, the disagreement between the bacteri-
al community structure determined by the cultivation-inde-
pendent approach and the bacterial isolation needs to be 
taken into account. 
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